Taurolidine lock in the treatment of colonization and infection of totally implanted venous access devices in cancer patients.
Fabrizio BresciaPittiruti MauroGiancarlo ScoppettuoloChiara ZanierElisa NadaliniPaola BottosChiara MorealValentina Da RosFabio FabianiPublished in: The journal of vascular access (2021)
In our retrospective analysis, 2% taurolidine lock was completely safe and highly effective in the treatment of both catheter-colonization and catheter-related bloodstream infection in cancer patients with totally implanted venous access devices.